Social Construction of Breast and Prostate Cancer Policy

Total Page:16

File Type:pdf, Size:1020Kb

Social Construction of Breast and Prostate Cancer Policy THE SOCIAL CONSTRUCTION OF BREAST AND PROSTATE CANCER POLICY by Jocilyn Martinez A Dissertation Submitted to the Faculty of The College of Architecture, Urban, & Public Affairs in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Florida Atlantic University Boca Raton, Florida May 2010 Copyright by Jocilyn Martinez 2010 ii ABSTRACT Author: Jocilyn Martinez Title: The Social Construction of Breast and Prostate Cancer Policy Institution: Florida Atlantic University Dissertation Advisor: Dr. Alka Sapat Degree: Doctor of Philosophy Year: 2010 Breast and prostate cancers are the most commonly diagnosed forms of cancer in women and men in the United States. The federal government has played an active role in dedicating resources toward breast and prostate cancers since the early 1990s, when policy actors successfully lobbied Congress to adopt policies that increased awareness and spending. Using theories of social construction, I argue that the key to their success was the ability of these policy actors to socially construct the illnesses of breast and prostate cancers into politically attractive public issues that appealed to federal policymakers. Through the use of embedded collective case study and content analysis of newspaper coverage and congressional data, this dissertation demonstrates how the iv social constructions of these illnesses impacted the way that breast and prostate cancers were treated as they moved through the policy process. The way in which social construction influenced the types of policies that were adopted to deal with these illnesses is also examined. Because social construction is a multidimensional and dynamic process, several different elements of this process were examined in this dissertation: the ways that policy actors attracted attention to these illnesses, how gender influenced advocacy efforts, the symbolic aspects of these illnesses, and the way the illnesses were defined on systemic and institutional agendas. Since this dissertation examines two different policy issues, the similarities and differences in breast and prostate cancer policymaking were analyzed. I found that discussing breast and prostate cancers in relation to their social constructions provides support for the importance of symbolism and non-rational policy-making processes. v THE SOCIAL CONSTRUCTION OF BREAST AND PROSTATE CANCER POLICY List of Tables…………………………………………………..……………...………x List of Figures…………………………………………………..…………………....xii Chapter I: Introduction…………………………………………..…………………….1 Breast and Prostate Cancer Policy……………………..………..……........4 Purpose and Research Questions……………………..……………………5 Significance of Research………………………………..………………...13 Organization of Dissertation…………………………..………………….16 Chapter II: Theoretical Foundations and Past Research……………..………………18 Social Construction and Policy……………………………..…...…….....22 Policy Actors Play a Role in Social Construction.……………..………...29 Gender and Advocacy.……………………………………..…………….32 Symbolic Politics………………………….…………………………..….34 Issues Reach the Policy Agenda…………………………………..……..37 Past Research on Breast and Prostate Cancer Policy……………..……...39 Conclusion………..……………….………………………………..……..44 Chapter III: Research Design and Methodology……………………..……………...45 Embedded Collective Case Study Analysis…………………..…….........46 vi Content Analysis………..…………………………………………..……48 Data Collection……………………………………………………..……50 Policy Actors and Advocacy Organizations…………..……..…….51 Newspaper Coverage………………………………………………52 Congressional Hearings….…………………………………..……55 Public Laws………………………………….……..……….…….56 Federal Research Funding…………………………..….…………57 Data Analysis…………………………………………………..………...58 Content Analysis of Newspaper Coverage…………………..…….59 Content Analysis of Congressional Hearings………………….…..63 Content Analysis of Policy Provisions in Public Laws……......…...70 Plan for Analysis………………………………………….…………...…75 Conclusion………………………………………………………….....…79 Chapter IV: Breast and Prostate Cancers Gain Attention and Move onto the Systemic Agenda…………………………………………..………...…80 Policy Actors Attract Attention……………………………..…...……..81 Breast Cancer Advocacy Groups and Entrepreneurs..………....…85 Prostate Cancer Advocacy Groups and Entrepreneurs ………..…90 A Typology of Breast and Prostate Cancer Policy Actors and Entrepreneurs ……………………….………………………..95 Symbols……………………………..………………………………..100 The Breast and Prostate as Symbols of Sexuality….…….……...101 vii Visual Symbols…………………………….……..….………….....103 Defining Breast and Prostate Cancers on the Systemic Agenda………...105 Tone of Newspaper Headlines…………….……..……………..…107 Content of Newspaper Headlines………………..…...………...….112 Conclusion.…………………..……………………………….…..…..…..120 Chapter V: Defining Breast and Prostate Cancers on the Institutional Agenda……………………………………………………………..…...121 Breast and Prostate Cancers on the Institutional Agenda…….........……122 Policy Actors Testify at Congressional Hearings…….……….…….......125 Rationales…….…………………………………………………….128 Stories of Decline…..……...………...…….…..………………….. 130 Personal Stories..……...……….…………..……..………...............133 Family………….…………………..………………..…….…….….135 Everyone…….……………………….……………..………..….…137 Burden……….………………………..……………..……..………139 Policy Goals……………………………………………………...…….142 Population Groups and Target Population Types…………………..….146 Policymakers Define Breast and Prostate Cancers………………..…...161 Conclusion…………………………………………………………..….169 Chapter VI: Breast and Prostate Cancer Policy Adoption……………………..…...170 Policy Adoption…………..…………………………..…………..…....171 Design Type……………………………………………………..…….172 viii Implementation…………….…………………………...………….…...176 Types of Policy Provisions……………………………………………..179 Population Groups and Target Population Types………….……..……187 Federal Research Funding………………………...……………..…….194 Conclusion……………………………………………………….…….203 Chapter VI: Conclusion………………………………………………………….....205 Research Questions…………..………………………….…………....206 Limitations……….…………………………………………………....213 Implications for Public Policy…….…………………………….....….216 Who Benefits from Breast and Prostate Cancer Policymaking?...........219 Future Directions for Research…………………………………….…224 Appendix A: Newspaper Headlines………………………………………...........…226 Appendix B: Congressional Hearings…………………………………………..…..257 Appendix C: Public Laws……………………………………………………..…....273 References…..……………………………………………………………………....281 ix LIST OF TABLES Table 2.1: Multiple Literature Streams …...……...……………………..…...………20 Table 2.2: Expectations of Breast and Prostate Cancer Policies…………..………...21 Table 3.1: Breast and Prostate Cancer Policy Actors and Advocacy Orgs……...…..52 Table 3.2: Coding Categories in Content Analysis of Newspaper Headlines…….....63 Table 3.3: Witness Categories in Content Analysis of Congressional Hearings.........64 Table 3.4: Codes for Witness Rationales in Content Analysis of Congressional Hearings................................................................................................65 Table 3.5: Policy Goals in Content Analysis of Congressional Hearings….....……..67 Table 3.6: Codes for Population Groups and Target Populations in Content Analysis of Congressional Hearings………………………………….68 Table 3.7: Coding of Design Type in Content Analysis of Policy Provisions…...….71 Table 3.8: Coding of Implementation in Content Analysis of Policy Provisions……………………………………………………………..72 Table 3.9: Provision Types in Content Analysis of Policy Provisions…..…………..73 Table 3.10: Codes for Population Groups and Target Populations in Content Analysis of Policy Provisions………………………………………75 Table 4.1: Typology of Breast and Prostate Cancer Policy Actors..………..............97 Table 4.2: Typology of Major Breast and Prostate Cancer Advocacy Orgs...………99 x Table 4.3: Tone Conveyed in Breast and Prostate Cancer Headlines…………........107 Table 4.4: Sub-Themes in Breast and Prostate Cancer Headlines…………….........114 Table 5.1: Policy Rationales in Congressional Breast and Prostate Cancer Debates……………………………………………………………....130 Table 5.2: Primary Rationales by Policymakers in Congressional Breast and Prostate Cancer Debates………………………………………….…163 Table 5.3: Target Populations Indentified from Policymakers’ Testimonies in Congressional Hearings……………………………………….……..164 Table 6.1: Comparisons of Target Populations Identified in Congressional Hearings and Policy Provisions……………………………………..188 Table 6.2: Federal Spending on Breast and Prostate Cancer Research ……………199 xi LIST OF FIGURES Figure 1.1: Social Construction and the Policy Process ………………………..…...13 Figure 4.1: Incidence Rates of Breast and Prostate Cancers (1980-2006)………..…83 Figure 4.2: No. of Newspaper Headlines on Breast and Prostate Cancers...…….....106 Figure 4.3: Time Series Analysis of Tone in Newspaper Headlines on Breast.........110 Figure 4.4: Time Series Analysis of Tone in Newspaper Headlines on Prostate Cancer……………………………………………………………...111 Figure 5.1: Congressional Hearings on Breast and Prostate Cancers 1990- 2006…………………………………………………………………123 Figure 5.2: Witnesses in Breast and Prostate Cancer Hearings………………..…...125 Figure 5.3: Policy Goals in Breast Cancer Congressional Hearings…………..…...143 Figure 5.4: Policy Goals in Prostate Cancer Congressional Hearings…..........…….145 Figure 5.5: Population Groups Identified in Breast and Prostate Cancer Congressional Hearings…………………………………………….148 Figure 5.6: Target Populations Identified in Congressional Hearings……………...149 Figure 6.1: Distributions of Benefits and Restrictions in Policy Provisions…….....173 Figure 6.2: Implementation Design of Policy Provisions……………………..……177 Figure 6.3: Types
Recommended publications
  • Breast Cancer Awareness Month October, 2016
    roclamation P BREAST CANCER AWARENESS MONTH OCTOBER, 2016 WHEREAS, October is National Breast Cancer Awareness Month, which is an annual campaign to increase awareness of this disease and while we have seen an increase in mammography rates and a decline in deaths there is more we can do and; WHEREAS, National Breast Cancer Awareness Month remains dedicated to increasing public knowledge about the importance of early detection of breast cancer diagnosis and treatment; and ; WHEREAS, too many women do not utilize mammography at regular intervals even though research indicates it is the best available method of detection to decrease death rates and ; WHEREAS, the awareness campaign is sending out several key messages, most notably, the American Cancer Society continues to advise women to get an annual mammogram screening once they reach age 40; and WHEREAS, the National Cancer Institute estimates in the United States, more than 231,000 (female) and 2, 000 (male) new cases of breast cancer will be diagnosed this year and over 40,000 people will die; and WHEREAS, in Somerset County, female breast cancer increased slightly and accounts for 16.3% of all cancer cases and 8.7% of all cancer deaths and are slightly higher than the average in New Jersey for incidence; and in Morris County, female breast cancer accounts for 15.8 % of all cancers and 9% of all cancer deaths and; WHEREAS, there are many organizations that continue to search for a cure through vital research, they also work with the Office of Cancer Control and Prevention in New Jersey
    [Show full text]
  • Fact Sheet Fiscal Year 2015-2016
    FACT SHEET FISCAL YEAR 2015-2016 THE ROSE SOUTHEAST 12700 N. Featherwood Drive, Suite 260 Houston, TX 77034 THE ROSE GALLERIA 5420 West Loop South, Suite 3300 Bellaire TX 77401 281.484.4708 Main Number 281.464.5136 Mobile Mammography TheRose.org [email protected] THE ROSE, is a not-for-profit 501(c)(3) breast cancer organization, offering a full range of breast cancer screening and diagnostic services including mammograms, ultrasounds, biopsies and access to treatment. This past year, The Rose served 38,176 patients with 7,113 of those being uninsured and sponsored. A total of 70,236 screening and diagnostic procedures were provided, 15,711 were sponsored. Most importantly, 323 women were diagnosed with breast cancer, of which 146 were sponsored. In 2016, The Rose served patients from 80 counties in Texas, with mobile mammography sites in 34 counties. Recognizing that with breast cancer, early detection saving lives, The Rose also provides breast health awareness within the community. In 2015-16, over 15,000 educational or outreach contacts were made. MISSION: Saving lives through quality breast health services, advocacy and access to care for all. Quality Breast Health Services--The Rose provides direct medical services including breast cancer screening, comprehensive diagnostics, physician consultation and patient navigation to treatment regardless of ability to pay. Advocacy- The Rose's leadership in advocacy encompasses one-on-one patient advocacy in obtaining critical diagnostic and treatment medical services as well as championing broader state and national issues that impact patient care. Access to Care- Core to The Rose's mission and its top priority is access to care for all.
    [Show full text]
  • EARLY DETECTION Breast Health Awareness and Clinical Breast Exam
    EARLY DETECTION Breast Health Awareness and Clinical Breast Exam Knowledge Summary EARLY DETECTION Breast Health Awareness and Clinical Breast Exam INTRODUCTION KEY SUMMARY Early diagnosis of breast cancer begins with the establish- Early detection programs ment of programs to improve early detection of symptomatic ¬ Early diagnosis of breast cancer can improve survival, lower women, or women with breast lumps that patients and their morbidity and reduces the cost of care when followed by a providers can feel. Early recognition of symptoms and accu- prompt diagnosis and effective treatment. rate diagnosis of breast cancer can result in cancers being diagnosed at earlier stages when treatment is more feasible, ¬ An effective early diagnosis program includes: affordable and effective. This requires that health systems √ Breast health awareness education. have trained frontline personnel who are able to recognize the √ Reducing barriers to accessing care. signs and symptoms of breast abnormalities for both benign √ Clinical breast exam (CBE) performed by primary care breast issues as well as cancers, perform clinical breast exam providers. (CBE) and know the proper referral protocol when diagnostic √ Timely diagnosis for all women found to have abnormal workup is warranted. Women who can identify breast abnor- findings and timely treatment for all women proven by malities, who have timely access to health clinical evaluation, tissue diagnosis to have breast cancer. diagnosis and treatment and who are empowered to seek this √ If supported by evidence, a quality screening mammogra- care are more likely to be diagnosed at an earlier stage (see phy program performed in a cost-effective, resource-sus- Planning: Improving Access to Breast Cancer Care).
    [Show full text]
  • “I Love Boobies”: the Influence of Sexualized Breast Cancer
    “I LOVE BOOBIES”: THE INFLUENCE OF SEXUALIZED BREAST CANCER CAMPAIGNS ON OBJECTIFICATION AND WOMEN’S HEALTH by ERIN ANN VANENKEVORT Bachelor of Science, 2009 Northern Michigan University Marquette, Michigan Submitted to the Graduate Faculty of the College of Science and Engineering Texas Christian University in partial fulfillment of the requirements for the degree of Masters of Science August 2014 ACKNOWLEDGEMENTS This project would not have been possible without the support of many people. Many thanks to my advisor, Dr. Cathy R. Cox, who read my many revisions, she guided me through unexpected results and helped me work through writing challenges. Also thanks to my committee members, Dr. Sarah Hill, and Dr. Charles Lord, who offered valuable input and support from start to finish. And finally, thanks to my research assistants, Trevor Swanson, Katrina Fazelimanesh, and Tracy Strazzini for helping organize and run countless study sessions to collect the necessary data. ii TABLE OF CONTENTS Acknowledgements………………………………………………………………………………. ii List of Figures……………………………………………………………………………………. v I. Reaction time as a function of breast cancer awareness………………………………... 11 II. BSE discomfort and Self-objectification scores as a function of video type…………… 17 III. Mediational analysis showing the role of objectification on the relationship between video prime and BSE……...…………………………………………………………………….19 IV. General helping attitude and average perceived risk of breast cancer as a function of video type……..………………………………………………………………………………...23 Introduction………………………………………………………………………………………
    [Show full text]
  • FCDS 2013 EDUCATION WEBCAST SERIES: BREAST CANCER Outline
    11/20/2013 FCDS 2013 EDUCATION WEBCAST SERIES: BREAST CANCER OVERVIEW, RISK FACTORS, ANATOMY, SCREENING, M P H RULES, STAGING, TUMOR MARKERS, TREATMENT Presented by: Steven Peace, BS, CTR Gema Midence, MBA, CTR Mayra Espino, BA, RHIT, CTR November 21, 2013 The North Portico exterior of the White House is illuminated pink in honor of Breast Cancer Awareness Month, Oct. 24, 2013 (Official White House Photo by Sonya N. Hebert) 2 Outline Overview 3 4 • Overview • Signs and Symptoms • Breast cancer is cancer that starts in the tissues of the breast. There • Anatomy of the Breast are two main types of breast • Screening Recommendations cancer: • Understanding Screening Results • Ductal carcinoma starts in the tubes (ducts) that move mild from • Breast Cancer Multiple Primary Rules the breast to the nipple. Most breast cancers are of this type. • Breast Cancer Histology Rules • Lobular carcinoma starts in the • Genetic and Biologic Tumor Markers parts of the breast, called lobules, • Breast Cancer Staging which produce milk. • In rare cases, breast cancer can • Treatment Planning start in other areas of the breast. • Coding Treatment Correctly • NCCN Treatment Guidelines Source: SEER Training Modules http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001911 • Text Documentation Overview 5 U.S. 2013 New Cases = 296,980 • 234,580 invasive cancers • 2,240 men • 64,640 in-situ cancers • 85% DCIS • 15% LCIS U.S. 2013 Deaths = 40,030 • 410 men Florida New Cases = 19,911 • 15,710 invasive cancers • 161 men • 4,201 in-situ cancers Breast Cancer Ranks Second
    [Show full text]
  • Incorporating Hereditary Cancer Syndrome Screening Into Daily
    SUPPLEMENT TO SEPTEMBER 2014 This supplement is sponsored by Myriad Genetic Laboratories Incorporating hereditary cancer syndrome screening into daily practice Shari Goldman Snow, MD Assistant Professor of Clinical Obstetrics and Gynecology Northwestern University Feinberg School of Medicine Chicago, IL CASE 1 Managing fibroids—and cancer risk— JOIN THE FIGHT AGAINST HEREDITARY in a patient with BRCA1 mutation BREAST AND OVARIAN CANCER: ASSESS EVERY PATIENT AT EVERY VISIT YH is a 40-year-old patient, G0P0, who presented for a second • September is Ovarian Cancer Awareness Month opinion regarding large uterine fibroids. Her previous gyne- • October is Breast Cancer Awareness Month cologist treated the fibroids conservatively with medication • September 28–October 4 is Hereditary Breast and a dilation and curettage (D&C) procedure. The patient’s and Ovarian Cancer (HBOC) Awareness Week menorrhagia became severe, however, leading to anemia. A • October 1 is National Previvor Day* hysterectomy was recommended, but the patient wanted a second opinion to discuss options for preserving her uterus. *Previvor: An individual who carries a strong predisposition to cancer but has not developed the disease. YH’s personal history was significant for fibroids, a D&C, and a breast biopsy. Her family history revealed that a paternal aunt was diagnosed with breast cancer at age 50, another paternal aunt was diagnosed with ovarian cancer s gynecologists, every day we face an increasing at age 50, and a paternal cousin was diagnosed with breast number of clinical issues to consider when seeing cancer at age 30. The patient underwent genetic testing, A our patients. While we strive for comprehensiveness, and mutation of the breast and ovarian cancer susceptibil- it is important to stratify our patient care to prioritize life- ity gene, BRCA1, was identified.
    [Show full text]
  • Extensions of Remarks 235 Extensions of Remarks
    January 23, 1990 EXTENSIONS OF REMARKS 235 EXTENSIONS OF REMARKS ELECTRIC VEHICLE TECHNOLO­ Unfortunately, electric vehicles have not But we do not have the luxury of waiting GY DEVELOPMENT AND DEM­ always been given the prominent role they de­ until electric vehicle battery technologies are ONSTRATION ACT OF 1990 serve in the national policy debate about alter­ perfected to move forward with a commercial­ native vehicle fuels. While there may be a ization program. If we do, electric vehicles HON. GEORGE E. BROWN, JR. number of reasons for this-some technologi­ simply will not be available in the mid-1990's OF CALIFORNIA cal, some economic-the real issue facing timeframe contemplated by the alternative IN THE HOUSE OF REPRESENTATIVES Congress today is how to move electric vehi­ fuels programs now under consideration. The technology available today is adequate for Tuesday, January 23, 1990 cles from the drawing boards onto our Na­ tion's roads, particularly in those urban areas certain applications, primarily for fleet use in Mr. BROWN of California. Mr. Speaker, I am where they can contribute significantly to air urban areas. Getting that technology on the pleased to introduce today the Electric Vehi­ quality improvement efforts. Even a combina­ road and creating niche markets for EV's cle Technology Development and Demonstra­ tion of regulatory mandates to use alternative offers us an effective means to pull private tion Act of 1990. This measure will help our fuels may not resolve the obstacles which sector research and development funds into Nation to achieve very important-and hereto­ combine to thwart the development of an battery programs at a far greater pace.
    [Show full text]
  • GAYLE A. SULIK [email protected]
    4-19-12 GAYLE A. SULIK [email protected] http://www.gaylesulik.com AREAS OF SPECIALIZATION Medical Sociology; Community-Based Research and Evaluation; Cancer Culture and Survivorship; Social Science Writing; Qualitative and Mixed Research Methods EDUCATION University at Albany (State University of New York) Ph.D., Sociology, 2004 M.A., Women’s Studies, 2001 University of Massachusetts at Amherst B.A., Anthropology, 1991 EMPLOYMENT Independent Scholar/Consultant Social Science Research, Writing, and Public Speaking Evaluation, Grant-writing, and Editorial Consulting Principal, founded June 2010 University at Albany (SUNY), Department of Women’s Studies Research Associate, August 2010 to 2013 Texas Woman’s University, Department of Sociology and Social Work Assistant Professor (Tenure-track), September 2007 to May 2010 Affiliate Faculty, Department of Women’s Studies, September 2007 to May 2010 Vassar College, Department of Sociology Assistant Professor (Visiting), August 2004 to May 2007 University at Albany (State University of New York), Department of Sociology Lecturer, September 2001- May 2004 College of St. Rose, Department of Sociology Lecturer, spring 2004 Capital Region Action Against Breast Cancer (CRAAB!) Executive Director, 2001-2002, Assistant to Director, 2000-2001 FELLOWSHIPS, GRANTS, AND AWARDS College of Arts and Sciences Research Development Funds, Texas Woman’s University, 2010 National Endowment for the Humanities, Research Fellowship Award, 2008-2009 Research Enhancement Program Award, Texas Woman’s University, 2008 Meadows Award for Excellence in Research, Sociology, University at Albany (SUNY), 2003 Initiatives for Women Feminist Research Award, University at Albany (SUNY), 2002 PROFESSIONAL EVALUATION, EDITING, AND TECHNICAL WRITING Evaluation Team, The Blue Foundation for a Healthy Florida Sapphire Award Competition, Blue Cross Blue Shield of Florida, 2009, 2010, 2011.
    [Show full text]
  • Kristen Connolly Helps Move 'Zoo' Far Ahead
    Looking for a way to keep up with local news, school happenings, sports events and more? 2 x 2" ad 2 x 2" ad We’ve got you covered! June 23 - 29, 2017 waxahachietx.com U J A M J W C Q U W E V V A H 2 x 3" ad N A B W E A U R E U N I T E D Your Key E P R I D I C Z J Z A Z X C O To Buying Z J A T V E Z K A J O D W O K W K H Z P E S I S P I J A N X and Selling! 2 x 3.5" ad A C A U K U D T Y O W U P N Y W P M R L W O O R P N A K O J F O U Q J A S P J U C L U L A Co-star Kristen Connolly L B L A E D D O Z L C W P L T returns as the third L Y C K I O J A W A H T O Y I season of “Zoo” starts J A S R K T R B R T E P I Z O Thursday on CBS. O N B M I T C H P I G Y N O W A Y P W L A M J M O E S T P N H A N O Z I E A H N W L Y U J I Z U P U Y J K Z T L J A N E “Zoo” on CBS (Words in parentheses not in puzzle) Jackson (Oz) (James) Wolk Hybrids Place your classified Solution on page 13 Jamie (Campbell) (Kristen) Connolly (Human) Population ad in the Waxahachie Daily 2 x 3" ad Mitch (Morgan) (Billy) Burke Reunited Light, Midlothian1 xMirror 4" ad and Abraham (Kenyatta) (Nonso) Anozie Destruction Ellis County Trading Post! Word Search Dariela (Marzan) (Alyssa) Diaz (Tipping) Point Kristen Connolly helps Call (972) 937-3310 © Zap2it move ‘Zoo’ far ahead 2 x 3.5" ad 2 x 4" ad 4 x 4" ad 6 x 3" ad 16 Waxahachie Daily Light Cardinals.
    [Show full text]
  • Breast Cancer Awareness Month Toolkit
    Breast Cancer Awareness Month Toolkit October 2020 October Is National Breast Cancer Awareness Month Other than skin cancer, breast cancer is the most common cancer in women. Breast cancer is also the second- leading cause of cancer death in women (after lung cancer). This is where you come in. October is National Breast Cancer Awareness Month. Together with the Wyoming Department of Health and the American Cancer Society, you can encourage women to take steps to help lower their risk of developing breast cancer and help find it early, when it might be easier to treat. You can also help connect women facing breast cancer to patient programs and services they might need throughout their treatment. We encourage you to share these messages during National Breast Cancer Awareness Month and throughout the year. Radio Ad Did you know that the best way to find breast cancer early is by getting screened? Breast cancer is easier to treat when it is found early. By the time there is a lump or other symptoms, the cancer may be at a more advanced stage. This is why women should get a mammogram every other year starting at age 50. Both men and women should talk to their doctor about their risk for breast cancer and which screening test is right for them. For information about free cancer screenings and other resources call the Wyoming Cancer Resource Services Program at {phone number}. Wyoming Cancer Resource Services is funded by the Wyoming Department of Health, Wyoming Cancer Program. Print Ad Social Media October is Breast Cancer Awareness Month.
    [Show full text]
  • Completeandleft
    MEN WOMEN 1. JA Jason Aldean=American singer=188,534=33 Julia Alexandratou=Model, singer and actress=129,945=69 Jin Akanishi=Singer-songwriter, actor, voice actor, Julie Anne+San+Jose=Filipino actress and radio host=31,926=197 singer=67,087=129 John Abraham=Film actor=118,346=54 Julie Andrews=Actress, singer, author=55,954=162 Jensen Ackles=American actor=453,578=10 Julie Adams=American actress=54,598=166 Jonas Armstrong=Irish, Actor=20,732=288 Jenny Agutter=British film and television actress=72,810=122 COMPLETEandLEFT Jessica Alba=actress=893,599=3 JA,Jack Anderson Jaimie Alexander=Actress=59,371=151 JA,James Agee June Allyson=Actress=28,006=290 JA,James Arness Jennifer Aniston=American actress=1,005,243=2 JA,Jane Austen Julia Ann=American pornographic actress=47,874=184 JA,Jean Arthur Judy Ann+Santos=Filipino, Actress=39,619=212 JA,Jennifer Aniston Jean Arthur=Actress=45,356=192 JA,Jessica Alba JA,Joan Van Ark Jane Asher=Actress, author=53,663=168 …….. JA,Joan of Arc José González JA,John Adams Janelle Monáe JA,John Amos Joseph Arthur JA,John Astin James Arthur JA,John James Audubon Jann Arden JA,John Quincy Adams Jessica Andrews JA,Jon Anderson John Anderson JA,Julie Andrews Jefferson Airplane JA,June Allyson Jane's Addiction Jacob ,Abbott ,Author ,Franconia Stories Jim ,Abbott ,Baseball ,One-handed MLB pitcher John ,Abbott ,Actor ,The Woman in White John ,Abbott ,Head of State ,Prime Minister of Canada, 1891-93 James ,Abdnor ,Politician ,US Senator from South Dakota, 1981-87 John ,Abizaid ,Military ,C-in-C, US Central Command, 2003-
    [Show full text]
  • Reproductions Supplied by EDRS Are the Best That Can Be Made from the Original Document
    DOCUMENT RESUME ED 449 105 SO 032 503 TITLE Maryland Women Who Dare: Paving the Way to the New Millennium. Maryland Women's History Display Kit 2000. INSTITUTION Maryland'State Dept. of Education, Baltimore. SPONS AGENCY Maryland State Dept. of Human Resources, Baltimore.; Maryland State Commission for Women, Baltimore. PUB DATE 2000-00-00 NOTE 160p.; This kit contains a booklet of activities and a packet of black and white photographs of notable Maryland women with profiles of their lives. AVAILABLE FROM Equity Assurance and Compliance Branch, Maryland State Department of Education, 200 West Baltimore Street, Baltimore, MD 21201. Tel: 410-767-0433. PUB TYPE Historical Materials (060) EDRS PRICE MF01/PC07 Plus Postage. DESCRIPTORS *Community Involvement; *Females; *Leaders; *Leadership; Leadership Qualities; *Recognition (Achievement); Secondary Education; Social Studies; State History; *Womens History IDENTIFIERS Biodata; *Maryland ABSTRACT This resource packet highlights over 30 contemporary Maryland women who reveal motivating stories from diverse backgrounds and occupations. The purpose of the packet is to recognize representative women of achievement and to ensure that teachers have the necessary tools to illustrate the extensive leadership and community involvement of Maryland women. The resource packet has three components:(1) display photographs of contemporary Maryland women;(2) descriptive captions to accompany each photograph; and (3)a resource booklet which contains a brief biographical profile of each woman pictured; personal reflections; suggested activities; and a resource directory. (BT) Reproductions supplied_by_EDRS are_the_best that can_be made from the original document. Maryland Women Who Dare: Paving the Way to the New Millennium. Maryland Women's History Display Kit 2000. Maryland State Dept.
    [Show full text]